Sudarshan Pharma Industries Ltd

As of March 31, 2026, Sudarshan Pharma Industries Ltd carries a market capitalization of 5.83B, placing it among publicly traded companies globally. Its enterprise value stands at 8.59B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Sudarshan Pharma Industries Ltd has 240.66M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Sudarshan Pharma Industries Ltd maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Sudarshan Pharma Industries Ltd recorded 68.13M in income tax expense.

As of the close on October 23, 2026, Sudarshan Pharma Industries Ltd's stock has gained approximately 23.42% over the past 52 weeks. The 50-day moving average sits at 37.97, while the 200-day moving average is 32.32.

As of March 31, 2026, Sudarshan Pharma Industries Ltd holds 108.57M in cash and equivalents against 2.85B in total debt, resulting in a net debt position of 2.82B. Total book value stands at 1.55B, with working capital of 341.46M providing operational flexibility.

Sudarshan Pharma Industries Ltd's most recent stock split took place on November 22, 2024 with a 1:10 split ratio.